CO224 Dupilumab Reduces Itch in Children with Moderate-to-Severe Atopic Dermatitis Aged 6 Months to 5 Years

A.S. Paller,E.C. Siegfried, G. Yosipovitch,S.G. Kwatra, A. Praestgaard, R. Prescilla, J. Wang

Value in Health（2023）

引用 0|浏览0

暂无评分

摘要

Considered the most burdensome symptom of atopic dermatitis (AD), intense itch has a negative impact on quality of life, sleep, and mental health. Dupilumab treatment led to sustained reduction of itch in studies involving adults, adolescents, and school-age children with AD. This analysis studied the impact of dupilumab treatment on itch in preschool-age children with moderate-to-severe AD.

查看译文

关键词

atopic dermatitis,itch,moderate-to-severe

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要